2024 HCPCS Code J1413
Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
TAGS: therapeutic delandistrogene
Short Description | Inj delandistrogene mox rokl |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 01, 2024 |
HCPCS Code Added Date | January 01, 2024 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J9199 - Injection, infugem, 200 mg
- J9200 - Floxuridine injection
- J9201 - In gemcitabine hcl nos 200mg
- J9202 - Goserelin acetate implant
- J9203 - Gemtuzumab ozogamicin 0.1 mg
- J9204 - Inj mogamulizumab-kpkc, 1 mg
- J9205 - Inj irinotecan liposome 1 mg
- J9206 - Irinotecan injection
- J9207 - Ixabepilone injection
- J9208 - Ifosfamide injection
- J9209 - Mesna injection
- J9210 - Inj., emapalumab-lzsg, 1 mg
- J9211 - Idarubicin hcl injection
- J9212 - Interferon alfacon-1 inj
- J9213 - Interferon alfa-2a inj
- J9214 - Interferon alfa-2b inj
- J9215 - Interferon alfa-n3 inj
- J9216 - Interferon gamma 1-b inj
- J9217 - Leuprolide acetate suspnsion
- J9218 - Leuprolide acetate injeciton